**PURPOSE:** Diabetes mellitus is the leading cause of non-healing wounds and lower extremity amputation in the US. We have previously implicated dysfunction of the Nrf2/Keap1 anti-oxidant pathway in this pathology, but the relative contribution of Nrf2 to physiologic and diabetic wound healing remains unknown.

**METHODS:** Excisional wounds were created in the dorsum of wild-type, diabetic, Nrf2-/-, and Nrf2+/- mice, and stented to prevent secondary contraction. Wound tissue was analyzed for oxidative damage (8-OhdG), gene expression, and re-epithelialization (epithelial gap).

**RESULTS:** Oxidative damage was greater in both diabetic (2.8 ng/mL) and Nrf2-/- (2.5 ng/mL) skin post-wounding as compared to wild-type (1.1 ng/mL) or Nrf2+/- (1.8 ng/mL, p\<.05). Intact skin of diabetic mice had 20% lower levels of Nrf2 gene expression relative to wild-type, and the differences persisted post-wounding (day 5: 27% day 7: 58%). Nrf2+/- mice had intermediate expression levels (day 5: 60%, p\<.02, day 7: 76%). Keap1, the physiologic repressor of Nrf2, was overexpressed in diabetic mice as compared to wild-type (intact: 171%, day 5: 253%, day 7: 118%) while it remained constant or decreased in Nrf2-/- mice (intact: 103%, day 5: 61%, day 7: 107%). Gene expression of NAD(P)H quinone dehydrogenase (NQO-1), an antioxidant enzyme activated by Nrf2, peaked later in diabetic (day 10) and Nrf2-/- (day 7) mice compared to wild-type and Nrf2+/- mice (day 5). NQO-1 was also decreased in both diabetic and Nrf2 -/- intact (2% and 30%, respectively p\<.05) and wounded tissue (11% and 8%, respectively p\<.05) as compared to wild-type, while Nrf2+/- displayed an intermediate phenotype (intact: 37%). At day 7 post-wounding, diabetic and Nrf2+/-wounds displayed the largest epithelial gap (9.7mm and 7.6mm, respectively). Wild-type mice had the smallest epithelial gap (4.1mm), while Nrf2-/- mice displayed an intermediate phenotype (7.0mm).

**CONCLUSION:** Here, we demonstrate the role of Keap1-mediated Nrf2 loss in impaired diabetic redox handling and wound-healing in an animal model. Our findings further validate this pathway as a promising target for therapies aimed at improving both diabetic and physiologic wound healing.
